Literature DB >> 18635658

Leptin regulates peripheral lipid metabolism primarily through central effects on food intake.

Xavier Prieur1, Y C Loraine Tung, Julian L Griffin, I Sadaf Farooqi, Stephen O'Rahilly, Anthony P Coll.   

Abstract

The metabolic effects of leptin may involve both centrally and peripherally mediated actions with a component of the central actions potentially independent of alterations in food intake. Ob/ob mice have significant abnormalities in lipid metabolism, correctable by leptin administration. We used ob/ob mice to study the relative importance of the subtypes of actions of leptin (central vs. peripheral; food intake dependent vs. independent) on lipid metabolism. Mice were treated for 3 d with leptin, either centrally [intracerebroventricular (icv)] or peripherally (ip), and compared with mice pair-fed to the leptin-treated mice (PF) and with ad libitum-fed controls (C). All treatment groups (icv, ip, PF) showed indistinguishable changes in liver weight; hepatic steatosis; hepatic lipidemic profile; and circulating free fatty acids, triglycerides, and cholesterol lipoprotein profile. Changes in the expression of genes involved in lipogenesis and fatty acid oxidation in liver, muscle, and white fat were broadly similar in ip, icv, and PF groups. Leptin (both icv and ip) stimulated expression of both mitochondrial and peroxisomal acyl-coenzyme A oxidase (liver) and peroxisomal proliferator-activated receptor-alpha (skeletal muscle) to an extent not replicated by pair feeding. Leptin had profound effects on peripheral lipid metabolism, but the majority were explained by its effects on food intake. Leptin had additional centrally mediated effects to increase the expression of a limited number of genes concerned with fatty acid oxidation. Whereas we cannot exclude direct peripheral effects of leptin on certain aspects of lipid metabolism, we were unable to detect any such effects on the parameters measured in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635658      PMCID: PMC2629739          DOI: 10.1210/en.2008-0498

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake.

Authors:  D L Silver; N Wang; A R Tall
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity.

Authors:  May-Yun Wang; Lelio Orci; Mariella Ravazzola; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

3.  Decreased food intake does not completely account for adiposity reduction after ob protein infusion.

Authors:  N Levin; C Nelson; A Gurney; R Vandlen; F de Sauvage
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

4.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  Yasuhiko Minokoshi; Young-Bum Kim; Odile D Peroni; Lee G D Fryer; Corinna Müller; David Carling; Barbara B Kahn
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

5.  Regulation of fatty acid homeostasis in cells: novel role of leptin.

Authors:  R H Unger; Y T Zhou; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 6.  Leptin: an essential regulator of lipid metabolism.

Authors:  S P Reidy; J Weber
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2000-03       Impact factor: 2.320

7.  Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.

Authors:  Coen H Wiegman; Robert H J Bandsma; Margriet Ouwens; Fjodor H van der Sluijs; Rick Havinga; Theo Boer; Dirk-Jan Reijngoud; Johannes A Romijn; Folkert Kuipers
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

8.  Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

Authors:  M Shimabukuro; K Koyama; G Chen; M Y Wang; F Trieu; Y Lee; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 9.  Leptin, leptin receptors, and the control of body weight.

Authors:  J M Friedman
Journal:  Nutr Rev       Date:  1998-02       Impact factor: 7.110

Review 10.  Leptin signaling in the central nervous system and the periphery.

Authors:  Christian Bjørbaek; Barbara B Kahn
Journal:  Recent Prog Horm Res       Date:  2004
View more
  25 in total

1.  Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve.

Authors:  Jonathan German; Francis Kim; Gary J Schwartz; Peter J Havel; Christopher J Rhodes; Michael W Schwartz; Gregory J Morton
Journal:  Endocrinology       Date:  2009-07-02       Impact factor: 4.736

2.  Leptin therapy in lipodystrophy.

Authors:  D B Savage; S O'Rahilly
Journal:  Diabetologia       Date:  2009-10-04       Impact factor: 10.122

3.  The lipoprivic control of feeding is governed by fat metabolism, not by leptin or adipose depletion.

Authors:  Bryan D Hudson; Alan J Emanuel; Michael F Wiater; Sue Ritter
Journal:  Endocrinology       Date:  2010-03-04       Impact factor: 4.736

4.  Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

Authors:  Shankar Munusamy; Jussara M do Carmo; Jonathan P Hosler; John E Hall
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

Review 5.  The impact of leptin on perinatal development and psychopathology.

Authors:  Jeanette C Valleau; Elinor L Sullivan
Journal:  J Chem Neuroanat       Date:  2014-05-23       Impact factor: 3.052

6.  Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity.

Authors:  James P Warne; Farzad Alemi; Alison S Reed; Jillian M Varonin; Helen Chan; Merisa L Piper; Mark E Mullin; Martin G Myers; Carlos U Corvera; Allison W Xu
Journal:  Cell Metab       Date:  2011-12-07       Impact factor: 27.287

Review 7.  The therapeutic potential of GPR43: a novel role in modulating metabolic health.

Authors:  Lauren M Cornall; Michael L Mathai; Deanne H Hryciw; Andrew J McAinch
Journal:  Cell Mol Life Sci       Date:  2013-07-14       Impact factor: 9.261

8.  Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy.

Authors:  Rebecca J Brown; Areli Valencia; Megan Startzell; Elaine Cochran; Peter J Walter; H Martin Garraffo; Hongyi Cai; Ahmed M Gharib; Ronald Ouwerkerk; Amber B Courville; Shanna Bernstein; Robert J Brychta; Kong Y Chen; Mary Walter; Sungyoung Auh; Phillip Gorden
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

9.  Transcriptional and pathway analysis in the hypothalamus of newly hatched chicks during fasting and delayed feeding.

Authors:  Stacy E Higgins; Laura E Ellestad; Nares Trakooljul; Fiona McCarthy; Jason Saliba; Larry A Cogburn; Tom E Porter
Journal:  BMC Genomics       Date:  2010-03-09       Impact factor: 3.969

10.  Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway.

Authors:  Lei Jiang; Qiong Wang; Yue Yu; Feng Zhao; Ping Huang; Rong Zeng; Robert Z Qi; Wenjun Li; Yong Liu
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.